Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study

Nail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23...

Full description

Saved in:
Bibliographic Details
Main Authors: Aikaterini Kyriakou, Aikaterini Patsatsi, Timoleon-Achilleas Vyzantiadis, Dimitrios Sotiriadis
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/508178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568270736064512
author Aikaterini Kyriakou
Aikaterini Patsatsi
Timoleon-Achilleas Vyzantiadis
Dimitrios Sotiriadis
author_facet Aikaterini Kyriakou
Aikaterini Patsatsi
Timoleon-Achilleas Vyzantiadis
Dimitrios Sotiriadis
author_sort Aikaterini Kyriakou
collection DOAJ
description Nail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23 p40, and IL-17 in psoriatic patients with and without nail involvement. 52 consecutively selected patients with chronic plaque psoriasis were included in this cross-sectional study. Patients were studied and analyzed after they had been divided into 2 groups regarding the presence (n = 24) or not (n = 28) of nail psoriasis. The mean serum levels of TNF-α were significantly higher in the group of psoriatic patients with nail lesions compared to those without (t-test; 5.40 ± 1.17 versus 3.80 ± 1.63, P = 0.026). However, the median serum levels of both IL-12/23 p40 (Mann-Whitney; 92.52 (34.35–126.87) versus 150.68 (35.18–185.86), P = 0.297) and IL-17 (Mann-Whitney; 28.49 (0.00–28.49) versus 8.59 (0.00–8.59), P = 0.714) did not significantly differ between the 2 groups. These results confirm the important role of TNF-α in the pathogenesis of nail psoriasis and may suggest that anti-TNF agents could be more beneficial in psoriatic nail disease than agents targeting IL-12/23 p40 or IL-17 and its receptors.
format Article
id doaj-art-1cfe15ea7aea4c9d9acf361af3b0d598
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-1cfe15ea7aea4c9d9acf361af3b0d5982025-02-03T00:59:18ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/508178508178Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional StudyAikaterini Kyriakou0Aikaterini Patsatsi1Timoleon-Achilleas Vyzantiadis2Dimitrios Sotiriadis32nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Ring Road Thessalonikis, Nea Efkarpia, 56403 Thessaloniki, Greece2nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Ring Road Thessalonikis, Nea Efkarpia, 56403 Thessaloniki, Greece1st Department of Microbiology, Aristotle University School of Medicine, 54124 Thessaloniki, Greece2nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Ring Road Thessalonikis, Nea Efkarpia, 56403 Thessaloniki, GreeceNail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23 p40, and IL-17 in psoriatic patients with and without nail involvement. 52 consecutively selected patients with chronic plaque psoriasis were included in this cross-sectional study. Patients were studied and analyzed after they had been divided into 2 groups regarding the presence (n = 24) or not (n = 28) of nail psoriasis. The mean serum levels of TNF-α were significantly higher in the group of psoriatic patients with nail lesions compared to those without (t-test; 5.40 ± 1.17 versus 3.80 ± 1.63, P = 0.026). However, the median serum levels of both IL-12/23 p40 (Mann-Whitney; 92.52 (34.35–126.87) versus 150.68 (35.18–185.86), P = 0.297) and IL-17 (Mann-Whitney; 28.49 (0.00–28.49) versus 8.59 (0.00–8.59), P = 0.714) did not significantly differ between the 2 groups. These results confirm the important role of TNF-α in the pathogenesis of nail psoriasis and may suggest that anti-TNF agents could be more beneficial in psoriatic nail disease than agents targeting IL-12/23 p40 or IL-17 and its receptors.http://dx.doi.org/10.1155/2014/508178
spellingShingle Aikaterini Kyriakou
Aikaterini Patsatsi
Timoleon-Achilleas Vyzantiadis
Dimitrios Sotiriadis
Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
The Scientific World Journal
title Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_full Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_fullStr Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_full_unstemmed Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_short Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_sort serum levels of tnf α il 12 23 p40 and il 17 in psoriatic patients with and without nail psoriasis a cross sectional study
url http://dx.doi.org/10.1155/2014/508178
work_keys_str_mv AT aikaterinikyriakou serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT aikaterinipatsatsi serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT timoleonachilleasvyzantiadis serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT dimitriossotiriadis serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy